Feedback / Questions
In-Vivo mRNA CAR-M targeting GPC-3 - Moderna
https://www.prnewswire.com/news-releases/carisma-therapeutics-announces-nomination-of-first-in-vivo-car-m-development-candidate-for-hepatocellular-carcinoma-under-collaboration-with-moderna-302185002.html
Jun 27, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next